Combination motexafin gadolinium (MGd) and docetaxel is active in recurrent lung and other solid tumors: Results of a phase 1 trial

Autor:	K. J. Pandya, S. C. Phan
Rok vydání:	2005
Předmět:	chemistry.chemical_classification Cancer Research Reactive oxygen species Lung business.industry chemistry.chemical_compound medicine.anatomical_structure Oncology chemistry Docetaxel Motexafin gadolinium Phase (matter) Cancer research Medicine business Redox cycling medicine.drug
Zdroj:	Journal of Clinical Oncology. 23:3138-3138
ISSN:	1527-7755 0732-183X
DOI:	10.1200/jco.2005.23.16_suppl.3138
Popis:	3138 Background: MGd is a novel anti-neoplastic agent that targets tumors and generates reactive oxygen species (ROS) by redox cycling. Pre-clinical models show that MGd enhances the cytotoxic acti...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::b3af7ec4b6d6566c72c9d95191b33759 https://doi.org/10.1200/jco.2005.23.16_suppl.3138 Zobrazit plný text záznamu